WT1 and kidney cancer: The identification of a mutation in the specific gene is important for the follow-up of these cases, particularly mutations in WT1 that are associated with risk of kidney cancer and gonadal and renal failure [30, 31]. NR5A1 mutations are associated with risk of adrenal insufficiency and primary ovarian failure [32–34].